Recent Trends In Clinical Trials In India

Eminent medical experts had considered 2011 as a roller coaster ride for the Indian clinical research industry

. The enthusiasm that sets in with India is gaining significance in the global biopharmaceutical landscape and the advent of robust innovation-led local industry got offset by a slowdown in the regulatory platform. Looking at the positive side, these challenges led the industry into action and was a catalyst for the industry, regulatory bodies and other main stakeholders to join hands on a shared environment to focus on essential issues pertaining to the medical field. All these led to even better developments in the year 2012.

It has been observed that the scope of the medical and clinical trial/research industry in India is vast and offers a great platform for clinical research organizations. The Indian clinical trial industry was evaluated to be at $485 million in 2010 by Frost & Sullivan with a 17 percent CGAR growth between the years 2009 and 2015. It has been estimated that this growth would be fouled by medical global giants as well as generic and innovative domestic enterprises who have experienced a quick growth over the past few years.

Furthermore, a huge and potential area of expansion is that of the biosimilar field, where a huge amount of unique and innovative research, development and experiments is going on in India. The potential for biosimilars sets up an enormous scope for the Biopharma organizations. However, contradictory to the development of progenitor biologic or generic versions of chemical based medication, the biosimilat developments are stated to be a complicated attempt that needs detailed planning, precision to make sure that of scheduled regulatory sanctions and optimal access to the market. As a result, the clinical development strategies need to concentrate on the patient selection and apt clinical endpoints. This serves as a scope for the clinical research organizations to join hands with Biopharma enterprises and assist them to go through the intricacies of the industry.

In the recent past, the Indian medical landscape has already started to witness alliances and partnerships between international CROs and other domestic Pharma players in the biosimilar vertical and this expected to grow all through 2012. Other growing scope in India is the data-generated healthcare services that include Biostatistics, data management, medical writing, Pharmacovigilance, bioavalability and so on. IT capacities and the ability to comprehend and process data through analytics are both essential to the new age clinical trials.

by: Gladeyas

POST COMMENT

Ngo For Disabled In India What Is Diwali Without Diwali Mithai In India? Australian Visa Consultancy Office In India Concrete Crusher India Sale Cathayphillips Send Variety Of Gifts To India On Navratri The Extraordinary Advantages When You Post A Free Classified Ad In India There Are Many Non-woven Bags Manufacturers In India Affordable Compact Muvs/ Suvs To Fuel The Growth Of Uv Segment In India Indias Top Holiday Destinations India Largest Project Wave City Center Sector 32 Noida Trip To South India: Best Place To Make Trip Memorable Shimla Kullu Manali - The Finest Hill Station Destinations In India Job Opportunity In The Field Of Information Technologies In India